このエントリーをはてなブックマークに追加


ID 64197
フルテキストURL
fulltext.pdf 1.27 MB
著者
Oka, Akihiro Department of Cardiology, Kagawa Prefectural Central Hospital
Sudo, Yuya Department of Cardiology, Kagawa Prefectural Central Hospital
Miyoshi, Toru Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons
Ozaki, Masatomo Department of Cardiology, Kagawa Prefectural Central Hospital
Kimura, Yuta Department of Cardiology, Kagawa Prefectural Central Hospital
Takagi, Wataru Department of Cardiology, Kagawa Prefectural Central Hospital
Ugawa, Satoko Department of Cardiology, Kagawa Prefectural Central Hospital
Okada, Tomoaki Department of Cardiology, Kagawa Prefectural Central Hospital
Nosaka, Kazumasa Department of Cardiology, Kagawa Prefectural Central Hospital
Doi, Masayuki Department of Cardiology, Kagawa Prefectural Central Hospital
抄録
Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.
キーワード
COVID-19 mRNA vaccination
fulminant myocarditis
steroid pulse therapy
発行日
2022-02-07
出版物タイトル
CLINICAL CASE REPORTS
10巻
2号
出版者
WILEY
開始ページ
e05378
ISSN
2050-0904
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2022 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1002/ccr3.5378
ライセンス
https://creativecommons.org/licenses/by-nc/4.0/